Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-021693
Filing Date
2025-08-13
Accepted
2025-08-13 21:09:33
Documents
1
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 form4-08142025_010830.html 4  
1 form4-08142025_010830.xml 4 6569
  Complete submission text file 0001415889-25-021693.txt   8011
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LYELL IMMUNOPHARMA, INC. 400 EAST JAMIE COURT, SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address
Hill Stephen J. (Reporting) CIK: 0001866154 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 251213832